Correction: Spiegelzymes® mirror-image hammerhead ribozymes and mirror-image DNAzymes, an alternative to siRNAs and microRNAs to cleave mRNAs in vivo? (PLoS ONE (2014) 9, 1 (e86673) DOI:10.1371/journal.pone.0086673);Spiegelzymes® mirror-image hammerhead ribozymes and mirror-image DNAzymes, an alternative to siRNAs and microRNAs to cleave mRNAs in vivo?

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Wyszko, Eliza ^a   Mueller, Florian ^b   Gabryelska, Marta ^a   Bondzio, Angelika ^c   Popenda, Mariusz ^a   Barciszewski, Jan ^a   Erdmann, Volker A ^c,d  

^a INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

^b Pentafolium Soft   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d Erdmann Technologies GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBOZYME; HAMMERHEAD RIBOZYME; MAGNESIUM; MESSENGER RNA; MICRORNA; MIRROR IMAGE DNAZYME; NUCLEIC ACID; SMALL INTERFERING RNA; SPIEGELZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BASE PAIRING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA STRUCTURE; ENANTIOMER; ENZYME ACTIVITY; ENZYME STABILITY; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; MOLECULAR MODEL; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN RNA BINDING; RNA CLEAVAGE; THREE DIMENSIONAL IMAGING;

ANIMALS; BASE PAIRING; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, CATALYTIC; HELA CELLS; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RNA; RNA CLEAVAGE; RNA STABILITY; RNA, CATALYTIC; RNA, MESSENGER; RNA, SMALL INTERFERING; STEREOISOMERISM;

EID: 84899799209     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093798     Document Type: Erratum

References (25)

1. Cava F, Lam H, de Pedro MA, Waldor MK (2011) Emerging knowledge of regulatory roles of D-amino acids in bacteria. Cell Mol Life Sci 68: 817-831.
2. Wyszko E, Szymanski M, Zeichhardt H, Mueller F, Barciszewski J, et al. (2013) Spigelzymes: Sequence specific hydrolysis with mirror image hammerhead ribozymes and DNAzymes. PLoS One (8)1: e5471.
3. Klussmann S, Nolte A, Bald R, Erdmann VA, Fürste JP (1996) Mirror-image RNA that binds D-adenosine. Nat Biotechnol 14: 1112-1115. (Pubitemid 26299110)
4. Nolte A, Klussmann S, Bald R, Erdmann VA, Fürste JP (1996) Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat Biotechnol 14: 1116-1119. (Pubitemid 26299111)
5. van Rooij E, Olson EN (2012) MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 11: 860-872.
6. Eulberg D, Jarosch F, Vonhoff S, Klussmann S (2006) Spiegelmers for therapeutic applications. In: Klussmann S, editor. The aptamer handbook, functional oligonucleotides and their applications. Weinheim: Wiley-VCH.
7. Oney S, Lam RT, Bompiani KM, Blake CM, Quick G, et al. (2009) Development of universal antidotes to control aptamer activity. Nat Med 15: 1224-1228.
8. Gaglione M, Messere A (2010) Recent progress in chemically modified siRNAs. Mini Rev Med Chem 10: 578-595.
9. Garbesi A, Capobianco ML, Colonna FP, Tondelli RG, Arcamone F, et al. (1993) L-DNAs as potential antimessenger oligonucleotides: a reassessment. Nucleic Acids Res 21: 4159-4165. (Pubitemid 23279000)
10. Blommers MJJ, Tondelli L, Garbesi A (1994) Effects of the introduction of L-nucleotides into DNA. Solution structure of the heterochiral duplex d(G-C-G-(L)T-G-C-G).d(C-G-C-A-C-G-C) studied by NMR spectroscopy. Biochemistry 33: 7886-7896. (Pubitemid 24223807)
11. Damha MJ, Giannaris PA, Marfey P (1994) Antisense L/D- oligodeoxynucleotide chimeras: nuclease stability, base-pairing properties, and activity at directing ribonuclease H. Biochemistry 33: 7877-7885. (Pubitemid 24223806)
12. Urata H, Ueda Y, Suhara H, Nishioka E, Akagi M (1993) NMR study of a heterochiral DNA: stable Watson-Crick-type base-pairing between the enantiomeric residues. J Am Chem Soc 115: 9852-9853.
13. Scott WG (2010) What can the new hammerhead ribozyme structures teach us about design? In: Erdmann VA, Barciszewski J, editors. RNA technologies and their applications. Berlin, Heidelburg: Springer-Verlag. pp. 305-324.
14. Chen X, Denison L, Levy M, Ellington AD (2009) Direct selection for ribozyme cleavage activity in cells. RNA 15: 2035-2045.
15. Olea C Jr, Horning DP, Joyce GF (2912) Ligand-dependent exponential amplification of a self-replicating L-RNA enzyme. J Am Chem Soc 134: 8050-8953.
16. Kurreck J, Wyszko E, Gillen C, Erdmann VA (2002) Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res 30: 1911-1918. (Pubitemid 34537585)
17. Santoro SW, Joyce GF (1997) A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci U S A 94: 4262-4266. (Pubitemid 27194229)
18. Ashley GW (1992) Modeling, synthesis, and hybridization properties of (L)-ribonucleic acid. J Amer Chem Soc 114: 9721-9736.
19. Fujimori S, Shudo K, Hashimoto Y (1990) Enantio-DNA recognizes complementary RNA but not complementary DNA. J Am Chem Soc 112: 7436-7438. (Pubitemid 20338671)
20. Burgess DJ (2012) Therapeutics: Antitumour potential of catalytic DNA. Nature Rev Cancer 12: 508-509.
21. Becker RC, Oney S, Becker KC, Rusconi CP, Sullenger B (2007) Nucleic acid aptamers and their complimentary antidotes. Heamostaseologie 27: 378-382.
22. Rusconi CP, Scardino E, Layzer J, Pitoc GA, Ortel TL, et al. (2002) RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419: 90-94. (Pubitemid 34987876)
23. Nimjee SM, Keys JR, Pitoc GA, Quick G, Rusconi CP, et al. (2006) A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery. Mol Ther 14: 408-415. (Pubitemid 44184966)
24. Wang J, Cao Y, Chen G, Li G (2009) Regulation of thrombin activity with a bifunctional aptamer and hemin: development of a new anticoagulant and antidote pair. Chembiochem 10: 2171-2176.
25. Boeckel CAA, Visser GM, Hegstrom RA, van Boom JH (1987) Amplification of chirality based upon the association of nucleic acid strands of opposite handedness. J Mol Evol 25: 100-105.